- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Alder Biopharmaceuticals Inc+ Add to Watchlist
3A9:GR8.866 EUR 0.109 1.21%
As of 02:02:07 ET on 09/17/2014.
Company Profile for Alder Biopharmaceuticals Inc (3A9)
Alder Biopharmaceuticals, Inc. provides pharmaceutical products and services. The Company offers identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas. Alder Biopharmaceuticals operates in the United States.
Alder Biopharmaceuticals Inc
Key Executives for Alder Biopharmaceuticals Inc (3A9)
|Randall C SchatzmanPresident/CEO/Co-Founder||Mark J LittonChief Bus Ofcr/Treasurer/Secy|
|John A LathamChief Scientific Ofcr/Co-Founder||Larry K BenedictSenior VP:Finance|
|Jeffrey T L SmithSenior VP:Translational Medicine|